TY  - GEN
AU  - Pellicelli,Adriano M
AU  - Montalbano,Marzia
AU  - Lionetti,Raffaella
AU  - Durand,Christine
AU  - Ferenci,Peter
AU  - D'Offizi,Gianpiero
AU  - Knop,Viola
AU  - Telese,Andrea
AU  - Lenci,Ilaria
AU  - Andreoli,Arnaldo
AU  - Zeuzem,Stefan
AU  - Angelico,Mario
TI  - Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: potent antiviral activity but no clinical benefit if treatment is given late
SN  - 1878-3562
PY  - 2015///0513
KW  - Adult
KW  - Aged
KW  - Antiviral Agents
KW  - therapeutic use
KW  - Carbamates
KW  - Compassionate Use Trials
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Female
KW  - Follow-Up Studies
KW  - Hepatitis C, Chronic
KW  - drug therapy
KW  - Humans
KW  - Imidazoles
KW  - Liver Transplantation
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Pyrrolidines
KW  - Recurrence
KW  - Severity of Illness Index
KW  - Sofosbuvir
KW  - Treatment Outcome
KW  - Uridine Monophosphate
KW  - analogs & derivatives
KW  - Valine
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study
UR  - https://doi.org/10.1016/j.dld.2014.06.004
ER  -